References
Banerjee R, Balaji M, Sasikala M, et al. Granulomas of intestinal tuberculosis and Crohn’s disease can be differentiated by CD73 cell surface marker expression: a pilot study. Dig Dis Sci. 2013;58:2301–2307.
Pulimood AB, Amarapurkar DN, Ghoshal U, et al. Differentiation of Crohn’s disease from intestinal tuberculosis in India in 2010. World J Gastroenterol. 2011;17:433–443.
Raghuvanshi S, Sharma P, Singh S, et al. Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells. Proc Natl Acad Sci USA. 2010;107:21653–21658.
Danese S, Rutella S, Vetrano S. Mesenchymal stromal cells in inflammatory bowel disease: conspirators within the ‘colitogenic niche’? Gut. 2013;62:1098–1099.
Colgan SP, Eltzschig HK, Eckle T, Thompson LF. Physiological roles for ecto-5′-nucleotidase (CD73). Purinergic Signal. 2006;2:351–360.
Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110:3499–3506.
Ciccocioppo R, Bernardo ME, Sgarella A, et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn’s disease. Gut. 2011;60:788–798.
Duijvestein M, Vos AC, Roelofs H, et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn’s disease: results of a phase I study. Gut. 2010;59:1662–1669.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Suprabha, N., Pai, C.G. Mesenchymal Stem Cells and Granulomas in Crohn’s Disease and Intestinal Tuberculosis: The Way Forward. Dig Dis Sci 58, 3641–3642 (2013). https://doi.org/10.1007/s10620-013-2909-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-013-2909-1